Aptamer TY04 inhibits the growth of multiple myeloma cells via cell cycle arrest

Tumor Biology

Volumn 35, Issue 8, 2014, Pages 7561-7568

  Dai, Hongjuan ^a   Ye, Mao ^b   Peng, Mingyuan ^a   Zhou, Weihua ^a   Bai, Huarong ^b   Xiao, Xiaojuan ^a   Ma, Bianying ^a   Zhou, Jiajie ^a   Tang, Shijun ^b   Yao, Shan ^b   Cao, Ye ^a   Qin, Zhiqiang ^c   Liu, Jing ^a   Tan, Weihong ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Aptamer; Cell cycle; Mitosis; Multiple myeloma; ssDNA

Indexed keywords

APTAMER; CCNB1 PROTEIN, HUMAN; CDK1 PROTEIN, HUMAN; CYCLIN B1; CYCLIN DEPENDENT KINASE; MEMBRANE PROTEIN;

CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MITOSIS; MULTIPLE MYELOMA; PATHOLOGY; TUMOR CELL LINE;

APTAMERS, NUCLEOTIDE; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN B1; CYCLIN-DEPENDENT KINASES; HUMANS; MEMBRANE PROTEINS; MITOSIS; MULTIPLE MYELOMA;

EID: 84922393984     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-1920-2     Document Type: Article

References (23)

1. Gentile M, Recchia AG, Mazzone C, Lucia E, Vigna E, Morabito F. Perspectives in the treatment of multiple myeloma. Expert Opin Biol Th. 2013;13:S1–S22.
2. Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Oncol. 2011;8:479–91.
3. Pandit SR. Multiple myeloma: treatment options for an incurable disease. J Assoc Physicians India. 2005;53:1060–4.
4. Ye M, Hu J, Peng M, Liu J, Liu J, Liu H, et al. Generating aptamers by Cell-SELEX for applications in molecular medicine. Int J Mol Sci. 2012;13:3341–53.
5. Gold L. The SELEX process: a surprising source of therapeutic and diagnostic compounds. Harvey Lect. 1995;91:47–57.
6. Famulok M, Mayer G, Blind M. Nucleic acid aptamers—from selection in vitro to applications in vivo. Acc Chem Res. 2000;33:591–9.
7. Ireson CR, Kelland LR. Discovery and development of anticancer aptamers. Mol Cancer Ther. 2006;5:2957–62.
8. Zhu G, Ye M, Donovan MJ, Song E, Zhao Z, Tan W. Nucleic acid aptamers: an emerging frontier in cancer therapy. Chem Commun (Camb). 2012;48:10472–80.
9. Soundararajan S, Wang L, Sridharan V, Chen W, Courtenay-Luck N, Jones D, et al. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol. 2009;76:984–91.
10. Sefah K, Shangguan D, Xiong X, O'Donoghue MB, Tan W. Development of DNA aptamers using Cell-SELEX. Nat Protoc. 2010;5:1169–85.
11. Cerchia L, Esposito CL, Jacobs AH, Tavitian B, de Franciscis V. Differential SELEX in human glioma cell lines. PLoS One. 2009;4:e7971.
12. Kampen KR. Membrane proteins: the key players of a cancer cell. J Membr Biol. 2011;242:69–74.
13. Chen CH, Chernis GA, Hoang VQ, Landgraf R. Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3. Proc Natl Acad Sci U S A. 2003;100:9226–31.
14. Li N, Nguyen HH, Byrom M, Ellington AD. Inhibition of cell proliferation by an anti-EGFR aptamer. PLoS One. 2011;6:e20299.
15. Germer K, Leonard M, Zhang X. RNA aptamers and their therapeutic and diagnostic applications. Int J Biochem Mol Biol. 2013;4:27–40.
16. Xiong Y, Connolly T, Futcher B, Beach D. Human D-type cyclin. Cell. 1991;65:691–9.
17. Harvey SL, Charlet A, Haas W, Gygi SP, Kellogg DR. Cdk1-dependent regulation of the mitotic inhibitor Wee1. Cell. 2005;122:407–20.
18. DiPaola RS. To arrest or not to G (2)-M Cell-cycle arrest: commentary re: A. K. Tyagi et al., Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G(2)-M arrest, and apoptosis. Clin. cancer res., 8: 3512-3519, 2002. Clin Cancer Res. 2002;8:3311-4.
19. Pines J. Mitosis: a matter of getting rid of the right protein at the right time. Trends Cell Biol. 2006;16:55–63.
20. Taylor SS, Scott MI, Holland AJ. The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation. Chromosom Res. 2004;12:599–616.
21. Job D, Valiron O, Oakley B. Microtubule nucleation. Curr Opin Cell Biol. 2003;15:111–7.
22. Julian M, Tollon Y, Lajoie-Mazenc I, Moisand A, Mazarguil H, Puget A, et al. gamma-Tubulin participates in the formation of the midbody during cytokinesis in mammalian cells. J Cell Sci. 1993;105:145–56.
23. Shu HB, Li Z, Palacios MJ, Li Q, Joshi HC. A transient association of gamma-tubulin at the midbody is required for the completion of cytokinesis during the mammalian cell division. J Cell Sci. 1995;108:2955–62.